bioRxivCell BiologyPreprint
iPSC-Derived Myotubes from ME/CFS Patients Reveal Signature Genes, Isoforms and Pathways with Drug Repurposing Potential
Dao NguyeniD, Trang T. T. TruongiD, Bruna PanizzuttiiD, Megan Ellis, Briana SpoldingiD, Courtney Swinton, Chiara C. BortolasciiD, Jenny Bryce, Jess Smith, Cassie FieldiD, Zoe Shih-Jung LiuiD, Jee Hyun KimiD, Michael BerkiD, Ken R. WalderiD
Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multisystem disorder. Its hallmark feature, post-exertional malaise (PEM), is a delayed and prolonged worsening of symptoms following even minor exertion. As PEM commonly includes muscle pain, weakness, exercise intolerance and impaired recovery, skeletal muscle dysfunction may contribute to its pathophysiology, but the underlying molecular processes remain poorly understood. We generated induced pluripotent stem cell-derived skeletal muscle myotubes from individuals with ME/CFS (n = 6) and healthy controls (n = 7) to investigate disease-associated transcriptomic alterations and identify potential therapeutic candidates. Myogenic progenitor cells from both groups differentiated into elongated, multinucleated myotubes expressing titin and myosin heavy chain, while qPCR profiling of myogenic differentiation markers further supported successful differentiation. Gene-level analysis identified three differentially expressed genes at an FDR-adjusted p < 0.05: ERVH48-1, CDX4 and SLC2A14. Isoform-switching analysis identified 16 genes with significant differential isoform usage, including CACNA1H, MIEF2, SMAD2 and CHD4. Gene set enrichment analysis identified broader pathway-level alterations involving RNA processing, protein synthesis, proteostasis, mitochondrial quality control, metabolism and muscle-related processes. Library of Integrated Network-based Cellular Signatures Phase 2 (LINCS2) analysis further prioritised 14 compounds associated with mitochondrial metabolism, glucose and lipid regulation, PPAR signalling, calcium and excitatory signalling, neuroimmune activity and cellular stress responses. Overall, ME/CFS iPSC-derived myotubes showed modest gene-level differences alongside broader isoform- and pathway-level alterations, supporting their use for investigating skeletal muscle biology and prioritising candidates for functional validation.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis or control serum
Audrey A. Ryback, C. B. Hillier, … Caroline Dalton·bioRxiv·Jun 3, 2025
- Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation
F. Ahmed, L. T. Vu, … A. Grimson·bioRxiv·Oct 13, 2022
- Emerin loss of function inhibits MyoD-driven differentiation of human iPSCs into skeletal myotubes
Tracy A Knight, Jessica Mella, … Abigail L. Buchwalter·bioRxiv·Sep 16, 2026
- Dysregulation of extracellular vesicle protein cargo in female ME/CFS cases and sedentary controls in response to maximal exercise
Ludovic Giloteaux, Katherine A. Glass, … Maureen R. Hanson·Journal of Extracellular VesiclesPeer-reviewed·Jan 1, 2024
- Epigenetic control of myogenic identity of human muscle stem cells in Duchenne Muscular Dystrophy
Jimmy Massenet, Michèle Weiss‐Gayet, … Bénédicte Chazaud·iSciencePeer-reviewed·Nov 8, 2024
- Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
E. Karhan, C. Gunter, … D. Unutmaz·bioRxiv·Dec 23, 2019